Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Asthma, Allergic
- Rhinitis Allergic
- Rhinoconjunctivitis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, double-blind, placebo-controlled, multi centre, parallel-group studyMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: During the trial, both the investigator and the included subjects will be unaware of the treatment each subject is receiving. The person in charge of data analysis will also not know the treatment assigned to each subject until the database has been closed. So that neither the subject nor the investigator knows what treatment each subject is receiving, all the trial medication is identical in terms of outer packaging and appearance.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 14 years and 65 years
- Gender
- Both males and females
Description
Double blind, multicenter, parallel placebo controlled study. It includes 150 subjects sensitised to mites, from 14 to 65 years of age. Medication treatment of 1 year. The main outcome: CSMS
Double blind, multicenter, parallel placebo controlled study. It includes 150 subjects sensitised to mites, from 14 to 65 years of age. Medication treatment of 1 year. The main outcome: CSMS
Tracking Information
- NCT #
- NCT04435990
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Daniel Pujadas, MD Quirón Palma de Mallorca Principal Investigator: Mario Tubella, MD Cenvi Medic, Barcelona Principal Investigator: Alfonso Malet, MD Allergocentre, Barcelona Principal Investigator: Miguel Ángel Añó, MD Alergocantabria, Santander Principal Investigator: Miguel Herrías, MD Clinica Privada Bilbao Principal Investigator: Antonio Letrán, MD Hospital HLA Jeréz Puerta del Sur Principal Investigator: Diego Gutiérrez, MD Clínica Virgen del Rosario, Algeciras Principal Investigator: Ignacio Garcia, MD Clinica Quirón Salud, Córdoba Principal Investigator: Manuel Barceló, MD Clinica Privada, Málaga. Principal Investigator: Mº José Pereira, MD Centro Médico Puerto, Jerez Principal Investigator: Isabella Raducán, MD Clínica TECMA, Alzira Principal Investigator: Noelia Colomer, MD Clínica IMED, Valencia Principal Investigator: Eugenia Margarita Campos, MD Clínica IMED, Elche Principal Investigator: César Alías, MD Clínica Corachan, Barcelona Principal Investigator: Joaquín Martín, MD Hospital POLUSA, Lugo
Get Well Soon